Trial Profile
The Oral Contraceptive Pill for Premenstrual Worsening of Depression.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Drospirenone/ethinylestradiol (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 06 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Dec 2012 Planned end date changed from 1 Jul 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
- 20 Jul 2011 Planned end date changed from 1 Jun 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.